Cancer, obesity, diabetes and antidiabetic drugs: is the fog clearing?
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer, obesity, diabetes and antidiabetic drugs: is the fog clearing?
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 14, Issue 2, Pages 85-99
Publisher
Springer Nature
Online
2016-08-09
DOI
10.1038/nrclinonc.2016.120
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Obesity-Associated Alterations in Inflammation, Epigenetics, and Mammary Tumor Growth Persist in Formerly Obese Mice
- (2016) E. L. Rossi et al. Cancer Prevention Research
- A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk
- (2016) Ruth C. Travis et al. CANCER RESEARCH
- Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals
- (2016) Jonathan N. Hofmann et al. CANCER RESEARCH
- Obesity and Cancer: The Oil that Feeds the Flame
- (2016) Joan Font-Burgada et al. Cell Metabolism
- High Sensitivity of an Ha-RAS Transgenic Model of Superficial Bladder Cancer to Metformin Is Associated with 240-Fold Higher Drug Concentration in Urine than Serum
- (2016) Z. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Pioglitazone use and risk of bladder cancer: population based cohort study
- (2016) Marco Tuccori et al. BMJ-British Medical Journal
- A Nested Case–Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
- (2016) Neil Murphy et al. PLOS MEDICINE
- Pioglitazone use and risk of bladder cancer: population based cohort study
- (2016) Marco Tuccori et al. BMJ-British Medical Journal
- Obesity and Cancer: Local and Systemic Mechanisms
- (2015) Neil M. Iyengar et al. Annual Review of Medicine
- The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes
- (2015) Pauline A. J. Vissers et al. BREAST CANCER RESEARCH AND TREATMENT
- Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial
- (2015) Sirwan M. Hadad et al. BREAST CANCER RESEARCH AND TREATMENT
- Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium
- (2015) C M Nagle et al. BRITISH JOURNAL OF CANCER
- Pre-existing diabetes and breast cancer prognosis among elderly women
- (2015) J Luo et al. BRITISH JOURNAL OF CANCER
- Complications of hyperglycaemia with PI3K–AKT–mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trials
- (2015) E Geuna et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer-drug induced insulin resistance: Innocent bystander or unusual suspect
- (2015) G. Ariaans et al. CANCER TREATMENT REVIEWS
- GLP-1R Agonists Promote Normal and Neoplastic Intestinal Growth through Mechanisms Requiring Fgf7
- (2015) Jacqueline A. Koehler et al. Cell Metabolism
- Pharmacological Inhibition of PI3K Reduces Adiposity and Metabolic Syndrome in Obese Mice and Rhesus Monkeys
- (2015) Ana Ortega-Molina et al. Cell Metabolism
- Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome
- (2015) Siegfried Ussar et al. Cell Metabolism
- Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade
- (2015) W. T. Iams et al. CLINICAL CANCER RESEARCH
- Drugging PI3K in cancer: refining targets and therapeutic strategies
- (2015) Timothy A Yap et al. CURRENT OPINION IN PHARMACOLOGY
- The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes
- (2015) Marco Tuccori et al. DIABETES CARE
- Incretin-Based Drugs and Adverse Pancreatic Events: Almost a Decade Later and Uncertainty Remains: Table 1
- (2015) Laurent Azoulay DIABETES CARE
- mTOR inhibitors and diabetes
- (2015) Bruno Vergès et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015
- (2015) Alan J. Garber et al. Endocrine Practice
- Obesity and cancer: mechanistic insights from transdisciplinary studies
- (2015) Emma H Allott et al. ENDOCRINE-RELATED CANCER
- Sitagliptin and pancreatic cancer risk in patients with type 2 diabetes
- (2015) Chin-Hsiao Tseng EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes
- (2015) James D. Lewis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Cardiometabolic Multimorbidity With Mortality
- (2015) Emanuele Di Angelantonio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Weight Gain After Breast Cancer Diagnosis and All-Cause Mortality: Systematic Review and Meta-Analysis
- (2015) Mary C. Playdon et al. JNCI-Journal of the National Cancer Institute
- Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
- (2015) Sil Kordes et al. LANCET ONCOLOGY
- Global burden of cancer attributable to high body-mass index in 2012: a population-based study
- (2015) Melina Arnold et al. LANCET ONCOLOGY
- Prostate cancer: 4 big questions
- (2015) Richard Hodson NATURE
- Neutrophil ageing is regulated by the microbiome
- (2015) Dachuan Zhang et al. NATURE
- Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
- (2015) Kristoffer Forslund et al. NATURE
- Pioglitazone—when is a prescription drug safe?
- (2015) Yoon Kong Loke et al. Nature Reviews Urology
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK
- (2015) Bernd Kowall et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality
- (2015) Emily Jane Gallagher et al. PHYSIOLOGICAL REVIEWS
- The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder
- (2015) Madhur Nayan et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Paradoxical effect of rapamycin on inflammatory stress-induced insulin resistance in vitro and in vivo
- (2015) Ping Yang et al. Scientific Reports
- Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies
- (2015) Lang Wu et al. Scientific Reports
- Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
- (2015) K. K. Tsilidis et al. BMJ-British Medical Journal
- Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care
- (2015) Ian J. Douglas et al. PLOS MEDICINE
- Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
- (2015) K. K. Tsilidis et al. BMJ-British Medical Journal
- Weight Gain After Breast Cancer Diagnosis and All-Cause Mortality: Systematic Review and Meta-Analysis
- (2015) Mary C. Playdon et al. JNCI-Journal of the National Cancer Institute
- Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk
- (2015) Marian L. Neuhouser et al. JAMA Oncology
- Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis
- (2015) Cecilia Bosco et al. PLoS One
- Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance
- (2015) Seon-Yeong Lee et al. PLoS One
- Cancer and bone fractures in observational follow-up of the RECORD study
- (2014) Nigel P. Jones et al. ACTA DIABETOLOGICA
- Obesity and the outcome of young breast cancer patients in the UK: the POSH study
- (2014) E. R. Copson et al. ANNALS OF ONCOLOGY
- Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies
- (2014) D. S. M. Chan et al. ANNALS OF ONCOLOGY
- Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial
- (2014) Andrea DeCensi et al. BREAST CANCER RESEARCH AND TREATMENT
- Type 2 diabetes and the risk of mortality among patients with prostate cancer
- (2014) Leah Bensimon et al. CANCER CAUSES & CONTROL
- The Use of Metformin in Patients with Prostate Cancer and the Risk of Death
- (2014) L. Bensimon et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Diabetes and Other Comorbidities in Breast Cancer Survival by Race/Ethnicity: The California Breast Cancer Survivorship Consortium (CBCSC)
- (2014) A. H. Wu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders
- (2014) S. Gandini et al. Cancer Prevention Research
- A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors
- (2014) I. Puzanov et al. CLINICAL CANCER RESEARCH
- Pancreatic Safety of Newer Incretin-Based Therapies: Are the "-tides" Finally Turning?
- (2014) S. Devaraj et al. DIABETES
- Androgen Receptor Roles in Insulin Resistance and Obesity in Males: The Linkage of Androgen-Deprivation Therapy to Metabolic Syndrome
- (2014) I.-C. Yu et al. DIABETES
- Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas
- (2014) Ronac Mamtani et al. DIABETES CARE
- Are Sulfonylurea and Insulin Therapies Associated With a Larger Risk of Cancer Than Metformin Therapy? A Retrospective Database Analysis
- (2014) Bernd Kowall et al. DIABETES CARE
- Metformin Does Not Affect Cancer Risk: A Cohort Study in the U.K. Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial
- (2014) Konstantinos K. Tsilidis et al. DIABETES CARE
- The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia
- (2014) Louise Bordeleau et al. DIABETES CARE
- Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study
- (2014) M. Gokhale et al. DIABETES OBESITY & METABOLISM
- The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis
- (2014) Z.-J. Zhang et al. DIABETES OBESITY & METABOLISM
- Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis
- (2014) Daniel Levin et al. DIABETOLOGIA
- Prostate Cancer, Prostate Cancer Death, and Death from Other Causes, Among Men with Metabolic Aberrations
- (2014) Christel Häggström et al. EPIDEMIOLOGY
- Adult Life after Childhood Cancer in Scandinavia: Diabetes mellitus following treatment for cancer in childhood
- (2014) Anna Sällfors Holmqvist et al. EUROPEAN JOURNAL OF CANCER
- Randomized Trial of a Telephone-Based Weight Loss Intervention in Postmenopausal Women With Breast Cancer Receiving Letrozole: The LISA Trial
- (2014) Pamela J. Goodwin et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of Diabetes Mellitus in Long-Term Survivors of Hodgkin Lymphoma
- (2014) Frederika A. van Nimwegen et al. JOURNAL OF CLINICAL ONCOLOGY
- Obesity and Cardiovascular Diseases
- (2014) Carl J. Lavie et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013
- (2014) Marie Ng et al. LANCET
- Overcoming Drug Development Bottlenecks With Repurposing: Repurposing biguanides to target energy metabolism for cancer treatment
- (2014) Michael Pollak NATURE MEDICINE
- Obesity and cancer—the evidence is fattening up
- (2014) Rudolf Kaaks et al. Nature Reviews Endocrinology
- Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment
- (2014) Amy G. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
- (2014) Ajay K. Gopal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Growth hormone-induced insulin resistance in human subjects involves reduced pyruvate dehydrogenase activity
- (2013) B. Nellemann et al. Acta Physiologica
- Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation
- (2013) Olga Moiseeva et al. AGING CELL
- Molecular Pathways: Adiponectin and Leptin Signaling in Cancer
- (2013) M. N. VanSaun CLINICAL CANCER RESEARCH
- The high incidence of steroid-induced hyperglycaemia in hospital
- (2013) Ashley C. Fong et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Global estimates of diabetes prevalence for 2013 and projections for 2035
- (2013) L. Guariguata et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Influence of glucocorticoids and growth hormone on insulin sensitivity in humans
- (2013) K. C. J. Yuen et al. DIABETIC MEDICINE
- Cancer detection rates following enrolment in a disease management programme for type 2 diabetes
- (2013) A. S. Geier et al. DIABETOLOGIA
- Management of Hyperglycemia in Diabetic Patients with Hematologic Malignancies During Dexamethasone Therapy
- (2013) Aidar Gosmanov et al. Endocrine Practice
- Androgen-deprivation Therapy and Diabetes Control Among Diabetic Men with Prostate Cancer
- (2013) Nancy L. Keating et al. EUROPEAN UROLOGY
- Metformin Use and All-Cause and Prostate Cancer–Specific Mortality Among Men With Diabetes
- (2013) David Margel et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Trial of Temsirolimus and Bevacizumab Versus Interferon Alfa and Bevacizumab in Metastatic Renal Cell Carcinoma: INTORACT Trial
- (2013) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- An Epidemiologic and Genomic Investigation Into the Obesity Paradox in Renal Cell Carcinoma
- (2013) A. Ari Hakimi et al. JNCI-Journal of the National Cancer Institute
- Modification of the Association Between Obesity and Lethal Prostate Cancer by TMPRSS2:ERG
- (2013) Andreas Pettersson et al. JNCI-Journal of the National Cancer Institute
- Hyperglycemia, Insulin Resistance, Impaired Pancreatic β-Cell Function, and Risk of Pancreatic Cancer
- (2013) Brian M. Wolpin et al. JNCI-Journal of the National Cancer Institute
- The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis
- (2013) Gitanjali M. Singh et al. PLoS One
- Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
- (2013) V. K. Ridaura et al. SCIENCE
- On-target Effects of GLP-1 Receptor Agonists on Thyroid C-cells in Rats and Mice
- (2013) Thomas J. Rosol TOXICOLOGIC PATHOLOGY
- Obesity paradox: Differential effects on cancer and noncancer mortality in patients with type 2 diabetes mellitus
- (2012) Chin-Hsiao Tseng ATHEROSCLEROSIS
- A prospective study of circulating adipokine levels and risk of multiple myeloma
- (2012) J. N. Hofmann et al. BLOOD
- The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality
- (2012) Danny R. Youlden et al. Cancer Epidemiology
- Metformin and the Risk of Cancer: Time-related biases in observational studies
- (2012) S. Suissa et al. DIABETES CARE
- Does Comorbidity Influence the Risk of Myocardial Infarction or Diabetes During Androgen-Deprivation Therapy for Prostate Cancer?
- (2012) Nancy L. Keating et al. EUROPEAN UROLOGY
- Obesity and incidence of lung cancer: A meta-analysis
- (2012) Yang Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Oral Insulin Secretagogues, Insulin, and Cancer Risk in Type 2 Diabetes Mellitus
- (2012) Chia-Hsuin Chang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it
- (2012) Heather A. Ferris et al. JOURNAL OF CLINICAL INVESTIGATION
- Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway
- (2012) Naifa L. Busaidy et al. JOURNAL OF CLINICAL ONCOLOGY
- A Prospective Study of Plasma Adiponectin and Pancreatic Cancer Risk in Five US Cohorts
- (2012) Ying Bao et al. JNCI-Journal of the National Cancer Institute
- PTEN Mutations as a Cause of Constitutive Insulin Sensitivity and Obesity
- (2012) Aparna Pal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucocorticoids and insulin resistance in children with acute lymphoblastic leukemia
- (2012) Eric J. Chow et al. PEDIATRIC BLOOD & CANCER
- Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
- (2012) Hiroshi Noto et al. PLoS One
- Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
- (2012) Michael N. Pollak Cancer Discovery
- The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
- (2012) L. Azoulay et al. BMJ-British Medical Journal
- Long-Term Risk of Incident Type 2 Diabetes and Measures of Overall and Regional Obesity: The EPIC-InterAct Case-Cohort Study
- (2012) PLOS MEDICINE
- The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database
- (2011) E. Raschi et al. ACTA DIABETOLOGICA
- Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer
- (2011) X. He et al. ANNALS OF ONCOLOGY
- Insulin Increases De Novo Steroidogenesis in Prostate Cancer Cells
- (2011) A. A. Lubik et al. CANCER RESEARCH
- Diabetes and Risk of Prostate Cancer: A study using the National Health Insurance
- (2011) C.-H. Tseng DIABETES CARE
- Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone: Interim report of a longitudinal cohort study
- (2011) J. D. Lewis et al. DIABETES CARE
- Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data
- (2011) T. P. van Staa et al. DIABETOLOGIA
- Cancer occurrence in Danish diabetic patients: duration and insulin effects
- (2011) B. Carstensen et al. DIABETOLOGIA
- IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer
- (2011) Carly Jade Dool et al. ENDOCRINE-RELATED CANCER
- Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies
- (2011) Michael Elashoff et al. GASTROENTEROLOGY
- Incretin Receptors in Non-Neoplastic and Neoplastic Thyroid C Cells in Rodents and Humans: Relevance for Incretin-Based Diabetes Therapy
- (2011) Beatrice Waser et al. NEUROENDOCRINOLOGY
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity
- (2011) Iris L. Romero et al. OBSTETRICS AND GYNECOLOGY
- Diabetes in Cushing syndrome: basic and clinical aspects
- (2011) Gherardo Mazziotti et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- A systematic review and meta-analysis of the relationship between body size and testicular cancer
- (2010) C C Lerro et al. BRITISH JOURNAL OF CANCER
- Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
- (2010) A. DeCensi et al. Cancer Prevention Research
- Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase
- (2010) Carolyn Algire et al. ENDOCRINE-RELATED CANCER
- Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-Analysis
- (2010) Kimberly S. Peairs et al. JOURNAL OF CLINICAL ONCOLOGY
- Body-Mass Index and Mortality among 1.46 Million White Adults
- (2010) Amy Berrington de Gonzalez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of Insulin-like Growth Factor-I in Starvation and Injury
- (2010) Jean-Paul Thissen et al. NUTRITION REVIEWS
- Diabetes Mellitus in Long-term Survivors of Childhood Cancer
- (2009) Lillian R. Meacham et al. ARCHIVES OF INTERNAL MEDICINE
- Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma
- (2009) Paul Haluska et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Do Cancer Cells Care If Their Host Is Hungry?
- (2009) Michael Pollak Cell Metabolism
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden
- (2009) J. M. Jonasson et al. DIABETOLOGIA
- Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
- (2009) H. M. Colhoun et al. DIABETOLOGIA
- The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
- (2009) C. J. Currie et al. DIABETOLOGIA
- Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
- (2009) L. G. Hemkens et al. DIABETOLOGIA
- Colorectal Cancer Outcomes, Recurrence, and Complications in Persons With and Without Diabetes Mellitus: A Systematic Review and Meta-Analysis
- (2009) Kelly B. Stein et al. DIGESTIVE DISEASES AND SCIENCES
- Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
- (2009) Antonino Belfiore et al. ENDOCRINE REVIEWS
- Impact of Diabetes Mellitus on Complications and Outcomes of Adjuvant Chemotherapy in Older Patients With Breast Cancer
- (2009) Tomasz P. Srokowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Hyperglycemia during Induction Therapy is Associated with Poorer Survival in Children with Acute Lymphocytic Leukemia
- (2009) Rona Y. Sonabend et al. JOURNAL OF PEDIATRICS
- Insulin glargine and malignancy: an unwarranted alarm
- (2009) Stuart J Pocock et al. LANCET
- Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial
- (2009) Lars Sjöström et al. LANCET ONCOLOGY
- Does pre-existing diabetes affect prostate cancer prognosis? A systematic review
- (2009) C F Snyder et al. PROSTATE CANCER AND PROSTATIC DISEASES
- The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase
- (2008) M. Zakikhani et al. Cancer Prevention Research
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
- (2008) Andrew G Renehan et al. LANCET
- Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis
- (2008) Jing Ma et al. LANCET ONCOLOGY
- Proliferative effects of insulin analogues on mammary epithelial cells
- (2008) Doris Mayer et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started